Anmeldung
Gruppen
Forscher/innen
Finanzierung
Ergebnisse
Jose Luis
Alonso Romero
Asociado Ciencias de la Salud
Universidad Europea de Madrid
Madrid, España
Sie sind in
Zusammenarbeiten
Universidad Europea de Madrid
Publikationen in Zusammenarbeit mit Forschern von Universidad Europea de Madrid (3)
2024
Preventing alpelisib-related hyperglycaemia in HR+/HER2−/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial
eClinicalMedicine, Vol. 71
2022
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study
BMC Cancer, Vol. 22, Núm. 1
2021
Pembrolizumab plus gemcitabine in the subset of triple-negative advanced breast cancer patients in the geicam/2015-04 (Pangea-breast) study
Cancers, Vol. 13, Núm. 21
Kontakt
Rechtlicher Hinweis
translate
de
arrow_drop_down
translate
de
arrow_drop_down
es
ca
eu
gl
en
fr